David Huang to win ARVO award for OCT work in ophthalmology

Dr. David Huang, Oregon Health and Science University Casey Eye Institute

Thanks to his work in optical coherence tomography (OCT) for ophthalmic imaging, Dr. David Huang of the Oregon Health and Science University Casey Eye Institute (Portland, OR) will receive the 2013 Friedenwald Award from the Association for Research in Vision and Ophthalmology (ARVO). Huang helped to pioneer OCT, recognizing that cross-sectional images could be generated and displayed in false color by scanning the laser measurement beam. Since then, OCT has emerged as a standard diagnostic in clinical ophthalmology and is used for the diagnosis and monitoring glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD).

The Friedenwald Award was established in 1957 as a memorial to Dr. Jonas S. Friedenwald, a distinguished researcher whose contributions encompassed the entire field of ophthalmic investigations. The Friedenwald and Proctor Awards are presented annually by ARVO to recognize outstanding research in the basic or clinical sciences as applied to ophthalmology.

The award will be presented to Huang at the 2013 ARVO Annual Meeting, to take place May 5–9, 2013, in Seattle, WA.


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow Laser Focus World on your iPhone or Android

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

NeuroVision receives $10M in financing for optical imaging device to detect Alzheimer's

NeuroVision Imaging has raised Series B financing for its optical imaging device to detect and monitor Alzheimer's disease early.  

Optical elastography method targets corneal disease, with implications for other eye diseases

Optical elastography could lead to more effective therapies for degenerative corneal disease and other eye diseases.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World